As practice group chair, Patrick C. Woolley has helped to grow the firm's Science and Technology practice from its inception to over 35 lawyers and scientists. In his practice, Mr. Woolley has worked in a variety of areas including patents, trademarks, copyright, licensing, litigation, trade secret litigation and business advice and guidance. His practice has included both domestic and foreign issues, with Mr. Woolley having done significant work in Australia, Canada, Europe and Japan. Mr. Woolley has worked with startup companies, federal agencies, individual inventors and university/research institutions. In particular, Mr. Woolley has managed the entire intellectual property portfolio for a Fortune 500 company, as well as for a major research institution. His duties have included patent and trademark preparation and prosecution, patentability secrets, freedom to operate opinions, licensing and asset management, product design around and development, business guidance for new products, and development of a portfolio to promote VC investment or sale of assets.
Mr. Woolley has issued numerous opinions on patentability, non-infringement, and validity related to food products and processes, insecticides, Aids drugs, opiates, stem cells, carrier drugs, asthma compositions and a range of chemical, biotech, and mechanical inventions. Mr. Woolley spends significant time on opinion work and counseling executives and boards.
